Skip to main content
Top
Published in: European Radiology 3/2017

01-03-2017 | Cardiac

Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric cardiovascular magnetic resonance discriminators when end-diastolic wall thickness ≥ 15 mm

Authors: Jonathan C. L. Rodrigues, Stephen Rohan, Amardeep Ghosh Dastidar, Iwan Harries, Christopher B. Lawton, Laura E. Ratcliffe, Amy E. Burchell, Emma C. Hart, Mark C. K. Hamilton, Julian F. R. Paton, Angus K. Nightingale, Nathan E. Manghat

Published in: European Radiology | Issue 3/2017

Login to get access

Abstract

Objectives

European guidelines state left ventricular (LV) end-diastolic wall thickness (EDWT) ≥15mm suggests hypertrophic cardiomyopathy (HCM), but distinguishing from hypertensive heart disease (HHD) is challenging. We identify cardiovascular magnetic resonance (CMR) predictors of HHD over HCM when EDWT ≥15mm.

Methods

2481 consecutive clinical CMRs between 2014 and 2015 were reviewed. 464 segments from 29 HCM subjects with EDWT ≥15mm but without other cardiac abnormality, hypertension or renal impairment were analyzed. 432 segments from 27 HHD subjects with EDWT ≥15mm but without concomitant cardiac pathology were analyzed. Magnitude and location of maximal EDWT, presence of late gadolinium enhancement (LGE), LV asymmetry (>1.5-fold opposing segment) and systolic anterior motion of the mitral valve (SAM) were measured. Multivariate logistic regression was performed. Significance was defined as p<0.05.

Results

HHD and HCM cohorts were age-/gender-matched. HHD had significantly increased indexed LV mass (110±27g/m2 vs. 91±31g/m2, p=0.016) but no difference in site or magnitude of maximal EDWT. Mid-wall LGE was significantly more prevalent in HCM. Elevated indexed LVM, mid-wall LGE and absence of SAM were significant multivariate predictors of HHD, but LV asymmetry was not.

Conclusions

Increased indexed LV mass, absence of mid-wall LGE and absence of SAM are better CMR discriminators of HHD from HCM than EDWT ≥15mm.

Key Points

Hypertrophic cardiomyopathy (HCM) is often diagnosed with end-diastolic wall thickness ≥15mm.
Hypertensive heart disease (HHD) can be difficult to distinguish from HCM.
Retrospective case-control study showed that location and magnitude of EDWT are poor discriminators.
Increased left ventricular mass and midwall fibrosis are independent predictors of HHD.
Cardiovascular magnetic resonance parameters facilitate a better discrimination between HHD and HCM.
Literature
1.
go back to reference Elliott PM, Anastasakis A, Borger MA et al (2014) 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 35:2733–2779CrossRefPubMed Elliott PM, Anastasakis A, Borger MA et al (2014) 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 35:2733–2779CrossRefPubMed
2.
go back to reference Gersh BJ, Maron BJ, Bonow RO et al (2011) 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg 142:e153–e203CrossRefPubMed Gersh BJ, Maron BJ, Bonow RO et al (2011) 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg 142:e153–e203CrossRefPubMed
3.
go back to reference Wicker P, Roudaut R, Haissaguere M et al (1983) Prevalence and significance of asymmetric septal hypertrophy in hypertension: an echocardiographic and clinical study. Eur Heart J 4:1–5CrossRefPubMed Wicker P, Roudaut R, Haissaguere M et al (1983) Prevalence and significance of asymmetric septal hypertrophy in hypertension: an echocardiographic and clinical study. Eur Heart J 4:1–5CrossRefPubMed
4.
go back to reference Myerson SG, Bellenger NG, Pennell DJ (2002) Assessment of left ventricular mass by cardiovascular magnetic resonance. Hypertension 39:750–755CrossRefPubMed Myerson SG, Bellenger NG, Pennell DJ (2002) Assessment of left ventricular mass by cardiovascular magnetic resonance. Hypertension 39:750–755CrossRefPubMed
6.
go back to reference Cardim N, Galderisi M, Edvardsen T et al (2015) Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association. Eur Heart J Cardiovasc Imaging 16:280CrossRefPubMed Cardim N, Galderisi M, Edvardsen T et al (2015) Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association. Eur Heart J Cardiovasc Imaging 16:280CrossRefPubMed
7.
go back to reference Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34:2159–2219CrossRefPubMed Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34:2159–2219CrossRefPubMed
8.
go back to reference Rudolph A, Abdel-Aty H, Bohl S et al (2009) Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol 53:284–291CrossRefPubMed Rudolph A, Abdel-Aty H, Bohl S et al (2009) Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol 53:284–291CrossRefPubMed
9.
go back to reference Puntmann VO, Jahnke C, Gebker R et al (2010) Usefulness of magnetic resonance imaging to distinguish hypertensive and hypertrophic cardiomyopathy. Am J Cardiol 106:1016–1022CrossRefPubMed Puntmann VO, Jahnke C, Gebker R et al (2010) Usefulness of magnetic resonance imaging to distinguish hypertensive and hypertrophic cardiomyopathy. Am J Cardiol 106:1016–1022CrossRefPubMed
10.
go back to reference Belenkov Y, Vikhert OA, Belichenko OI, Arabidze GG (1992) Magnetic resonance imaging of cardiac hypertrophy in malignant arterial hypertension. Am J Hypertens 5:195S–199SPubMed Belenkov Y, Vikhert OA, Belichenko OI, Arabidze GG (1992) Magnetic resonance imaging of cardiac hypertrophy in malignant arterial hypertension. Am J Hypertens 5:195S–199SPubMed
12.
go back to reference Cooper LT, Baughman KL, Feldman AM et al (2007) The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol. 50(19):1914–1931 Cooper LT, Baughman KL, Feldman AM et al (2007) The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol. 50(19):1914–1931
13.
go back to reference Maceira A, Prasad S, Khan M, Pennell D (2006) Normalized Left Ventricular Systolic and Diastolic Function by Steady State Free Precession Cardiovascular Magnetic Resonance. J Cardiovasc Magn Reson 8:417–426CrossRefPubMed Maceira A, Prasad S, Khan M, Pennell D (2006) Normalized Left Ventricular Systolic and Diastolic Function by Steady State Free Precession Cardiovascular Magnetic Resonance. J Cardiovasc Magn Reson 8:417–426CrossRefPubMed
14.
go back to reference Childs H, Ma L, Ma M et al (2011) Comparison of long and short axis quantification of left ventricular volume parameters by cardiovascular magnetic resonance, with ex-vivo validation. J Cardiovasc Magn Reson 13:40CrossRefPubMedPubMedCentral Childs H, Ma L, Ma M et al (2011) Comparison of long and short axis quantification of left ventricular volume parameters by cardiovascular magnetic resonance, with ex-vivo validation. J Cardiovasc Magn Reson 13:40CrossRefPubMedPubMedCentral
15.
go back to reference Schulz-Menger J, Bluemke DA, Bremerich J et al (2013) Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson 15:35CrossRefPubMedPubMedCentral Schulz-Menger J, Bluemke DA, Bremerich J et al (2013) Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson 15:35CrossRefPubMedPubMedCentral
16.
go back to reference Rodriguez CJ, Diez-Roux AV, Moran A et al (2010) Left ventricular mass and ventricular remodeling among Hispanic subgroups compared with non-Hispanic blacks and whites: MESA (Multi-ethnic Study of Atherosclerosis). J Am Coll Cardiol 55:234–242CrossRefPubMedPubMedCentral Rodriguez CJ, Diez-Roux AV, Moran A et al (2010) Left ventricular mass and ventricular remodeling among Hispanic subgroups compared with non-Hispanic blacks and whites: MESA (Multi-ethnic Study of Atherosclerosis). J Am Coll Cardiol 55:234–242CrossRefPubMedPubMedCentral
17.
go back to reference Buchner S, Debl K, Haimerl J et al (2009) Electrocardiographic diagnosis of left ventricular hypertrophy in aortic valve disease: evaluation of ECG criteria by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 11:18. doi:10.1186/1532-429X-11-18 Buchner S, Debl K, Haimerl J et al (2009) Electrocardiographic diagnosis of left ventricular hypertrophy in aortic valve disease: evaluation of ECG criteria by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 11:18. doi:10.​1186/​1532-429X-11-18
18.
go back to reference Johansson B, Maceira AM, Babu-Narayan SV et al (2007) Clefts can be seen in the basal inferior wall of the left ventricle and the interventricular septum in healthy volunteers as well as patients by cardiovascular magnetic resonance. J Am Coll Cardiol 50:1294–1295CrossRefPubMed Johansson B, Maceira AM, Babu-Narayan SV et al (2007) Clefts can be seen in the basal inferior wall of the left ventricle and the interventricular septum in healthy volunteers as well as patients by cardiovascular magnetic resonance. J Am Coll Cardiol 50:1294–1295CrossRefPubMed
19.
go back to reference Petersen SE, Selvanayagam JB, Wiesmann F, et al. (2005) Left Ventricular Non-Compaction Insights From Cardiovascular Magnetic Resonance Imaging. J Am Coll Cardiol. 46(1):101–105 Petersen SE, Selvanayagam JB, Wiesmann F, et al. (2005) Left Ventricular Non-Compaction Insights From Cardiovascular Magnetic Resonance Imaging. J Am Coll Cardiol. 46(1):101–105
20.
go back to reference Lee PT, Dweck MR, Prasher S et al (2013) Left ventricular wall thickness and the presence of asymmetric hypertrophy in healthy young army recruits: data from the LARGE heart study. Circ Cardiovasc Imaging 6:262–267CrossRefPubMed Lee PT, Dweck MR, Prasher S et al (2013) Left ventricular wall thickness and the presence of asymmetric hypertrophy in healthy young army recruits: data from the LARGE heart study. Circ Cardiovasc Imaging 6:262–267CrossRefPubMed
21.
go back to reference Dweck MR, Joshi S, Murigu T et al (2012) Left ventricular remodeling and hypertrophy in patients with aortic stenosis: insights from cardiovascular magnetic resonance. J Cardiovasc Magn Reson 14:50CrossRefPubMedPubMedCentral Dweck MR, Joshi S, Murigu T et al (2012) Left ventricular remodeling and hypertrophy in patients with aortic stenosis: insights from cardiovascular magnetic resonance. J Cardiovasc Magn Reson 14:50CrossRefPubMedPubMedCentral
22.
go back to reference Mahrholdt H, Wagner A, Judd RM et al (2005) Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 26:1461–1474CrossRefPubMed Mahrholdt H, Wagner A, Judd RM et al (2005) Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 26:1461–1474CrossRefPubMed
23.
go back to reference Chirinos JA, Segers P, De Buyzere ML et al (2010) Left ventricular mass: allometric scaling, normative values, effect of obesity, and prognostic performance. Hypertension 56:91–98CrossRefPubMedPubMedCentral Chirinos JA, Segers P, De Buyzere ML et al (2010) Left ventricular mass: allometric scaling, normative values, effect of obesity, and prognostic performance. Hypertension 56:91–98CrossRefPubMedPubMedCentral
24.
go back to reference Sipola P, Magga J, Husso M et al (2011) Cardiac MRI assessed left ventricular hypertrophy in differentiating hypertensive heart disease from hypertrophic cardiomyopathy attributable to a sarcomeric gene mutation. Eur Radiol 21:1383–1389CrossRefPubMed Sipola P, Magga J, Husso M et al (2011) Cardiac MRI assessed left ventricular hypertrophy in differentiating hypertensive heart disease from hypertrophic cardiomyopathy attributable to a sarcomeric gene mutation. Eur Radiol 21:1383–1389CrossRefPubMed
25.
go back to reference Olivotto I, Maron MS, Autore C et al (2008) Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 52:559–566CrossRefPubMed Olivotto I, Maron MS, Autore C et al (2008) Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 52:559–566CrossRefPubMed
26.
go back to reference Rodrigues JCL, Amadu AM, Dastidar AG et al (2015) Prevalence and predictors of asymmetric hypertensive heart disease: insights from cardiac and aortic function with cardiovascular magnetic resonance. Eur Heart J Cardiovasc Imaging. doi:10.1093/ehjci/jev329 Rodrigues JCL, Amadu AM, Dastidar AG et al (2015) Prevalence and predictors of asymmetric hypertensive heart disease: insights from cardiac and aortic function with cardiovascular magnetic resonance. Eur Heart J Cardiovasc Imaging. doi:10.​1093/​ehjci/​jev329
27.
go back to reference Moon JCC, Fisher NG, McKenna WJ, Pennell DJ (2004) Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart 90:645–649CrossRefPubMedPubMedCentral Moon JCC, Fisher NG, McKenna WJ, Pennell DJ (2004) Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart 90:645–649CrossRefPubMedPubMedCentral
28.
go back to reference Frielingsdorf J, Franke A, Kühl HP et al (2001) Evaluation of septal hypertrophy and systolic function in diseases that cause left ventricular hypertrophy: a 3-dimensional echocardiography study. J Am Soc Echocardiogr 14:370–377CrossRefPubMed Frielingsdorf J, Franke A, Kühl HP et al (2001) Evaluation of septal hypertrophy and systolic function in diseases that cause left ventricular hypertrophy: a 3-dimensional echocardiography study. J Am Soc Echocardiogr 14:370–377CrossRefPubMed
29.
go back to reference Kuruvilla S, Janardhanan R, Antkowiak P et al (2015) Increased extracellular volume and altered mechanics are associated with LVH in hypertensive heart disease, not hypertension alone. JACC Cardiovasc Imaging 8:172–180CrossRefPubMedPubMedCentral Kuruvilla S, Janardhanan R, Antkowiak P et al (2015) Increased extracellular volume and altered mechanics are associated with LVH in hypertensive heart disease, not hypertension alone. JACC Cardiovasc Imaging 8:172–180CrossRefPubMedPubMedCentral
30.
go back to reference Varnava AM, Elliott PM, Sharma S et al (2000) Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart 84:476–482CrossRefPubMedPubMedCentral Varnava AM, Elliott PM, Sharma S et al (2000) Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart 84:476–482CrossRefPubMedPubMedCentral
31.
go back to reference Treibel TA, Zemrak F, Sado DM et al (2015) Extracellular volume quantification in isolated hypertension - changes at the detectable limits? J Cardiovasc Magn Reson 17:74CrossRefPubMedPubMedCentral Treibel TA, Zemrak F, Sado DM et al (2015) Extracellular volume quantification in isolated hypertension - changes at the detectable limits? J Cardiovasc Magn Reson 17:74CrossRefPubMedPubMedCentral
33.
go back to reference Hinojar R, Varma N, Child N et al (2015) T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study. Circ Cardiovasc Imaging. doi:10.1161/CIRCIMAGING.115.003285 PubMed Hinojar R, Varma N, Child N et al (2015) T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study. Circ Cardiovasc Imaging. doi:10.​1161/​CIRCIMAGING.​115.​003285 PubMed
34.
Metadata
Title
Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric cardiovascular magnetic resonance discriminators when end-diastolic wall thickness ≥ 15 mm
Authors
Jonathan C. L. Rodrigues
Stephen Rohan
Amardeep Ghosh Dastidar
Iwan Harries
Christopher B. Lawton
Laura E. Ratcliffe
Amy E. Burchell
Emma C. Hart
Mark C. K. Hamilton
Julian F. R. Paton
Angus K. Nightingale
Nathan E. Manghat
Publication date
01-03-2017
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 3/2017
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-016-4468-2

Other articles of this Issue 3/2017

European Radiology 3/2017 Go to the issue